Hepatitis Monthly

Published by: Kowsar

Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience

Olympia E Anastasiou 1 , * , Matthias Büchter 1 , Hideo A Baba 2 , Johannes Korth 3 , Ali Canbay 1 , Guido Gerken 1 and Alisan Kahraman 1
Authors Information
1 Department of Gastroenterology and Hepatology, University Hospital, University Duisburg Essen, Germany
2 Department of Pathology, University Hospital, University Duisburg Essen, Germany
3 Department of Nephrology, University Hospital, University Duisburg Essen, Germany
Article information
  • Hepatitis Monthly: November 01, 2016, 16 (11); e40737
  • Published Online: October 31, 2016
  • Article Type: Research Article
  • Received: July 12, 2016
  • Revised: September 5, 2016
  • Accepted: September 30, 2016
  • DOI: 10.5812/hepatmon.40737

To Cite: Anastasiou O E, Büchter M, Baba H A, Korth J, Canbay A, et al. Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience, Hepat Mon. 2016 ; 16(11):e40737. doi: 10.5812/hepatmon.40737.

Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology. 2010; 139(1): 58-72 e4[DOI][PubMed]
  • 2. Czaja AJ, Freese DK, American Association for the Study of Liver D. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002; 36(2): 479-97[DOI][PubMed]
  • 3. Lindor KD, Bru C, Jorgensen RA, Rakela J, Bordas JM, Gross JB, et al. The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology. 1996; 23(5): 1079-83[DOI][PubMed]
  • 4. Pinzani M, Vizzutti F, Arena U, Marra F. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography. Nat Clin Pract Gastroenterol Hepatol. 2008; 5(2): 95-106[DOI][PubMed]
  • 5. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38(2): 518-26[DOI][PubMed]
  • 6. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006; 43(6): 1317-25[DOI][PubMed]
  • 7. Hsieh YY, Tung SY, Lee IL, Lee K, Shen CH, Wei KL, et al. FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis. Chang Gung Med J. 2009; 32(6): 614-22[PubMed]
  • 8. Giannini E, Botta F, Fasoli A, Ceppa P, Risso D, Lantieri PB, et al. Progressive liver functional impairment is associated with an increase in AST/ALT ratio. Dig Dis Sci. 1999; 44(6): 1249-53[PubMed]
  • 9. Assy N, Minuk GY. Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults. Am J Gastroenterol. 2000; 95(6): 1545-50[DOI][PubMed]
  • 10. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007; 45(4): 846-54[DOI][PubMed]
  • 11. Abdollahi M, Pouri A, Ghojazadeh M, Estakhri R, Somi M. Non-invasive serum fibrosis markers: A study in chronic hepatitis. Bioimpacts. 2015; 5(1): 17-23[DOI][PubMed]
  • 12. Anastasiou J, Alisa A, Virtue S, Portmann B, Murray-Lyon I, Williams R. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy. Eur J Gastroenterol Hepatol. 2010; 22(4): 474-80[DOI][PubMed]
  • 13. Luth S, Herkel J, Kanzler S, Frenzel C, Galle PR, Dienes HP, et al. Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis. J Clin Gastroenterol. 2008; 42(8): 926-30[DOI][PubMed]
  • 14. Jung MK, Cho HJ, Lee HC, Park KS, Seo EH, Jeon SW, et al. [Comparison of transient elastography and hepatic fibrosis assessed by histology in chronic liver disease]. Korean J Gastroenterol. 2008; 51(4): 241-7[PubMed]
  • 15. Abdo AA. Clinical presentation, response to therapy, and predictors of fibrosis in patients with autoimmune hepatitis in Saudi Arabia. Saudi J Gastroenterol. 2006; 12(2): 73-6[PubMed]
  • 16. Wang QX, Shen L, Qiu DK, Bao H, Chen XY, Zeng MD, et al. [Validation of transient elastography (Fibroscan) in assessment of hepatic fibrosis in autoimmune hepatitis]. Zhonghua Gan Zang Bing Za Zhi. 2011; 19(10): 782-4[DOI][PubMed]
  • 17. Xu Q, Sheng L, Bao H, Chen X, Guo C, Li H, et al. Evaluate of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis. J Gastroenterol Hepatol. 2016; [DOI][PubMed]
  • 18. Hartl J, Denzer U, Ehlken H, Zenouzi R, Peiseler M, Sebode M, et al. Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis. J Hepatol. 2016; 65(4): 769-75[DOI][PubMed]
  • 19. Gutkowski K, Hartleb M, Kacperek-Hartleb T, Kajor M, Mazur W, Zych W, et al. Laboratory-based scoring system for prediction of hepatic inflammatory activity in patients with autoimmune hepatitis. Liver Int. 2013; 33(9): 1370-7[DOI][PubMed]
  • 20. Fabbri A, Lenzi M. Non-invasive markers of inflammation in autoimmune hepatitis. Liver Int. 2013; 33(9): 1295-7[DOI][PubMed]
  • 21. Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008; 48(1): 169-76[DOI][PubMed]
  • 22. Helmreich-Becker I, Schirmacher P, Denzer U, Hensel A, Meyer zum Buschenfelde KH, Lohse AW. Minilaparoscopy in the diagnosis of cirrhosis: superiority in patients with Child-Pugh A and macronodular disease. Endoscopy. 2003; 35(1): 55-60[DOI][PubMed]
  • 23. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996; 24(2): 289-93[DOI][PubMed]
  • 24. Schirmacher P, Fleig WE, Tannapfel A, Langner C, Dries V, Terracciano L, et al. [Bioptic diagnosis of chronic hepatitis. Results of an evidence-based consensus conference of the German Society of Pathology, of the German Society for Digestive and Metabolic Diseases and of Compensated Hepatitis (HepNet)]. Pathologe. 2004; 25(5): 337-48[DOI][PubMed]
  • 25. Shiha G, Zalata K. Ishak Versus METAVIR: Terminology, Convertibility and Correlation with Laboratory Changes in Chronic Hepatitis C, Liver Biopsy 2011;
  • 26. Ganne-Carrie N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology. 2006; 44(6): 1511-7[DOI][PubMed]
  • 27. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006; 55(3): 403-8[DOI][PubMed]
  • 28. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005; 128(2): 343-50[PubMed]
  • 29. Kamphues C, Lotz K, Rocken C, Berg T, Eurich D, Pratschke J, et al. Chances and limitations of non-invasive tests in the assessment of liver fibrosis in liver transplant patients. Clin Transplant. 2010; 24(5): 652-9[DOI][PubMed]
  • 30. Beckebaum S, Iacob S, Klein CG, Dechene A, Varghese J, Baba HA, et al. Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients. Transplantation. 2010; 89(8): 983-93[DOI][PubMed]
  • 31. Floreani A, Cazzagon N, Martines D, Cavalletto L, Baldo V, Chemello L. Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. Dig Liver Dis. 2011; 43(11): 887-92[DOI][PubMed]
  • 32. Corpechot C, Carrat F, Poujol-Robert A, Gaouar F, Wendum D, Chazouilleres O, et al. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology. 2012; 56(1): 198-208[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments